22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

  • Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Reduced Nicotine Tobacco
    • VLN®
    • Clinical Studies & Commentaries
  • Hemp/Cannabis Innovation
    • GVB Biopharma
  • Hops Research
  • News
  • Investors
    • Overview
    • New Investor / Latest Resources
    • Events
    • News
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports
    • FAQs
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • New Investor / Latest Resources
  • Events
  • News
    • Press Releases
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Trades
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Annual Reports
  • FAQs
  • News

  • Press Releases
Feb 01, 2022 12:30pm EST

22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes

Jan 26, 2022 11:00am EST

22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale

Jan 21, 2022 8:00am EST

22nd Century Group Appoints James A. Mish to Its Board of Directors

Jan 18, 2022 8:00am EST

22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less

Jan 03, 2022 2:23pm EST

22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022

Dec 23, 2021 11:46am EST

FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product

Dec 14, 2021 4:05pm EST

Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group

Dec 10, 2021 9:20am EST

22nd Century Ready to Provide Full Commercial Support to New Zealand’s Plan to Reduce Nicotine Content of All Cigarettes

Nov 19, 2021 8:30am EST

22nd Century Group Announces CFO Transition

Nov 15, 2021 9:20am EST

22nd Century Group Applauds Califf Nomination as FDA Commissioner

RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...38
    Next
    • Email Alerts
    • Contact
    • RSS News Feed
    © 2023 22nd Century Group, Inc. All Rights Reserved.
    Privacy Policy / CCPA Disclaimer Sitemap